Want to join the conversation?
Biotechnology company $GILD said that the authorization to market the once-daily single tablet regimen Genvoya for the treatment of HIV-1 infection in adults & adolescents has been granted by the European Commission. This authorization is supported by the 48-week data from two ongoing Phase 3 studies among 1,733 treatment-naive adult patients.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.